A Dual-Mode Imaging Nanoparticle Probe Targeting PD-L1 for Triple-Negative Breast Cancer

<div>Characterization of SPIO-aPD-L1-Cy5.5. (a) TEM imaging, (b) the mean sizes, (c) the zeta potential, (d) the time-dependent size and zeta potential of SPIO-aPD-L1-Cy5.5, (e) the emission spectra, and (f) the excitation spectra.</div>

Contrast Media & Molecular Imaging

fig2

Figure 2

Figure 2: A Dual-Mode Imaging Nanoparticle Probe Targeting PD-L1 for Triple-Negative Breast Cancer 